Determinants of cervical cytological abnormalities among HIV-positive women receiving care in a tertiary health facility in Southeast Nigeria

2019 ◽  
Vol 17 (2) ◽  
pp. 31
Author(s):  
JosephOdirichukwu Ugboaja ◽  
ChikaFlorence Ubajaka ◽  
EmmanuelOkwudili Oranu ◽  
CharlotteBlanche Oguejiofor ◽  
ChinekwuSochukwu Anyaoku ◽  
...  
Keyword(s):  
Health Facility ◽  
Hiv Positive ◽  
Hiv Positive Women ◽  
Cytological Abnormalities

Incidence of Cytological Abnormalities in Pap's Smear in HIV Positive Women

2018 ◽  
Vol 2 (S1) ◽  
pp. e000136
Author(s):  
Suhana Jotva ◽  
Hemani Desai ◽  
Hansa Goswami
Keyword(s):  
Trichomonas Vaginalis ◽  
Clinical History ◽  
Hiv Positive ◽  
Squamous Intraepithelial Lesions ◽  
Squamous Cells ◽  
Medical College ◽  
Hiv Positive Women ◽  
Cytological Abnormalities ◽  
Intraepithelial Lesions ◽  
Hiv Negative

Aims and Objectives: The aim of present study is to estimate the frequency of abnormal PAP’s smears and mainly to detect precancerous and cancerous lesions as well as inflammatory lesions in HIV infected women. Methodology: Our study was a retrospective study of total 130 cases and PAP’s smears were examined in cytology section in Department of Pathology, BJ Medical College, Ahmedabad from 1st March 2017 to 31st August 2017. Both HIV positive and HIV negative patients were included in the study. 80 patients were HIV negative and 50 patients were HIV positive. The clinical history and relevant parameters were noted. All the smears were processed by a conventional method using Papanicolaou stain.  Results: Out of 130 cases, 118 cases were reported negative for intraepithelial lesions or malignancy (NILM). Five cases were positive for squamous intraepithelial lesions (SIL) out of which four were HIV positive. Seven cases were of atypical squamous cells of undetermined significance (ASCUS) out of which 5 were HIV positive. Three cases were showing bacterial vaginosis. 1 case was showing Trichomonas Vaginalis. 19 cases were showing changes of non-specific inflammation. 6 cases were showing atrophic changes.  Conclusion: HIV infected women are at more risk to develop cervical cytological abnormalities. The study revealed a maximum number of non-specific inflammatory smears followed by smears showing atrophic changes. Smears suspicious for malignancy (ASCUS) and smears showing squamous intraepithelial lesions (SIL) were more common in HIV positive patients. Thus regular PAP’s smears screening as recommended by National AIDS Control Organization (NACO) will help in early detection of cervical abnormalities in HIV positive women. 

Relationships Between Responsibility Placement in Autobiographical Narratives and Health in HIV-Positive Women With Abuse Histories

2011 ◽  
Author(s):  
Gwendolyn Kelso ◽  
Sannisha K. Dale ◽  
Cheryl Watson ◽  
Kathleen Weber ◽  
Yeasol Lee ◽  
...  
Keyword(s):  
Hiv Positive ◽  
Autobiographical Narratives ◽  
Hiv Positive Women

The Bio/Necropolitics of ACTG 076: Lessons from Pregnant Women of Colour Living with HIV for Treatment for Prevention in the Twenty-first Century

Somatechnics ◽  
2020 ◽  
Vol 10 (2) ◽  
pp. 233-253
Author(s):  
Eli Manning
Keyword(s):  
Hiv Transmission ◽  
Ethical Dilemmas ◽  
Hiv Treatment ◽  
First Century ◽  
Hiv Positive ◽  
Treatment As Prevention ◽  
People Living With Hiv ◽  
Hiv Positive Women ◽  
Aids Clinical Trials ◽  
Living With Hiv

Since the pharmaceutical turn, using HIV treatment to prevent transmission is increasingly common. Treatment as Prevention®, or TasP, has relied on HIV treatment to prevent HIV transmission, targeting people living with HIV. However, TasP is predicated on troublesome heterosexist, classist, and racist medical practices borrowed from various times and spaces that enact biopolitical and necropolitical relations. This paper discusses the debate surrounding the first clinical trial that used HIV treatment to prevent transmission from woman-to-foetus. The 1994 landmark AIDS Clinical Trials Group 076 study laid the groundwork for using HIV treatment to prevent HIV transmission, the essential precursor to TasP. By examining the concerns of HIV positive women of colour and other AIDS activists, we are able to understand the ethical dilemmas and practical consequences that still haunt today's game-changing uses of HIV treatment for prevention and to see how biopolitics and necropolitics persist in TasP.

The risk of cardiovascular diseases in HIV-positive women

2016 ◽  
Vol 7 (1) ◽  
pp. 51-55
Author(s):  
Agata Skrzat-Wojdacz ◽  
Justyna D. Kowalska
Keyword(s):  
Cardiovascular Diseases ◽  
Hiv Positive ◽  
Hiv Positive Women
Sign in / Sign up

Export Citation Format

Share Document